A
Alpha Tau Medical Ltd
NASDAQ:DRTS
Alpha Tau Medical Ltd
NASDAQ:DRTS
Price:
7.88
USD
0.64%
Market Cap:
$693.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Alpha Tau Medical Ltd
NASDAQ:DRTS
|
IL |
|
BNK Financial Group Inc
KRX:138930
|
KR |
|
Orient Overseas (International) Ltd
OTC:OROVY
|
HK |
|
Jamna Auto Industries Ltd
NSE:JAMNAAUTO
|
IN |
|
Royal Helium Ltd
XTSX:RHC
|
CA |
|
Petrolia Energy Corp
OTC:BBLS
|
US |
|
N
|
NanoString Technologies Inc
OTC:NSTGQ
|
US |
|
ITC Ltd
NSE:ITC
|
IN |
|
Premier Pacific Construction Inc
OTC:PPCQ
|
US |
|
G
|
Grown Rogue International Inc
CNSX:GRIN
|
CA |
|
C
|
Cuscapi Berhad
KLSE:CUSCAPI
|
MY |
|
Black Diamond Group Ltd
TSX:BDI
|
CA |
|
mBank SA
OTC:MBAKF
|
PL |
|
Amotiv Ltd
ASX:AOV
|
AU |
|
Vantiva SA
PAR:VANTI
|
FR |
Balance Sheet
Balance Sheet Decomposition
Alpha Tau Medical Ltd
Alpha Tau Medical Ltd
Balance Sheet Decomposition is not available for
Alpha Tau Medical Ltd
Alpha Tau Medical Ltd
Balance Sheet
Alpha Tau Medical Ltd
Alpha Tau Medical Ltd
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
2
|
16
|
23
|
6
|
13
|
14
|
12
|
|
| Cash Equivalents |
2
|
16
|
23
|
6
|
13
|
14
|
12
|
|
| Short-Term Investments |
26
|
30
|
8
|
99
|
69
|
46
|
61
|
|
| Total Receivables |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
1
|
2
|
1
|
2
|
4
|
5
|
5
|
|
| Total Current Assets |
30
|
48
|
33
|
107
|
86
|
64
|
78
|
|
| PP&E Net |
2
|
5
|
8
|
13
|
21
|
22
|
27
|
|
| PP&E Gross |
2
|
5
|
8
|
13
|
21
|
22
|
27
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
2
|
3
|
4
|
5
|
|
| Other Long-Term Assets |
0
|
0
|
2
|
0
|
0
|
0
|
0
|
|
| Total Assets |
32
N/A
|
53
+68%
|
42
-20%
|
120
+185%
|
107
-11%
|
86
-20%
|
106
+23%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
3
|
4
|
4
|
|
| Accrued Liabilities |
1
|
1
|
3
|
3
|
4
|
5
|
7
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
2
|
4
|
4
|
7
|
9
|
11
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
6
|
6
|
6
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
5
|
5
|
19
|
10
|
10
|
9
|
12
|
|
| Total Liabilities |
7
N/A
|
8
+15%
|
23
+207%
|
15
-37%
|
23
+58%
|
24
+3%
|
29
+21%
|
|
| Equity | ||||||||
| Common Stock |
25
|
54
|
54
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
17
|
26
|
53
|
87
|
116
|
148
|
190
|
|
| Additional Paid In Capital |
17
|
17
|
18
|
192
|
200
|
210
|
267
|
|
| Total Equity |
25
N/A
|
46
+82%
|
19
-58%
|
106
+451%
|
84
-20%
|
63
-26%
|
77
+23%
|
|
| Total Liabilities & Equity |
32
N/A
|
53
+68%
|
42
-20%
|
120
+185%
|
107
-11%
|
86
-20%
|
106
+23%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
69
|
69
|
69
|
69
|
70
|
70
|
88
|
|
Switch to:
Switch to:
See Also
Discover More
